LON:PXS Provexis (PXS) Share Price, News & Analysis GBX 0.94 -0.09 (-8.26%) As of 07:54 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsBuy This Stock About Provexis Stock (LON:PXS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Provexis alerts:Sign Up Key Stats Today's Range 0.80▼ 1.0350-Day Range 0.90▼ 1.2552-Week Range 0.45▼ 1.55Volume178,038 shsAverage Volume2.86 million shsMarket Capitalization£22.15 millionP/E RatioN/ADividend Yield5.06%Price TargetN/AConsensus RatingN/A Company Overview Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom. Read More Receive PXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Provexis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PXS Stock News HeadlinesProvexis Secures Shareholder Support and Advances in Chinese MarketNovember 21, 2025 | tipranks.comAIM Market Roundup: Provexis, Geo Exploration, SabienNovember 19, 2025 | sg.finance.yahoo.comNobody Understands Why Trump Is Invading Iran (here’s the answer)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.May 19 at 1:00 AM | Banyan Hill Publishing (Ad)Provexis Faces Temporary Trading Suspension Amid Financial Reporting DelaySeptember 30, 2025 | tipranks.comPhase I trial finds topical PXS-6302 generally well tolerated in established skin scarsSeptember 12, 2025 | msn.comProvexis (LON:PXS) Is In A Strong Position To Grow Its BusinessJune 28, 2025 | finance.yahoo.comParagon Care Limited (PXS) Receives a Buy from Ord MinnettFebruary 28, 2025 | markets.businessinsider.comProvexis Grants Options and Warrants to CEO and ConsultantsJanuary 7, 2025 | tipranks.comSee More Headlines PXS Stock Analysis - Frequently Asked Questions How have PXS shares performed this year? Provexis' stock was trading at GBX 0.90 at the beginning of the year. Since then, PXS stock has increased by 4.9% and is now trading at GBX 0.94. How were Provexis' earnings last quarter? Provexis plc (LON:PXS) posted its quarterly earnings data on Wednesday, December, 31st. The company reported ($0.01) EPS for the quarter. Provexis had a negative trailing twelve-month return on equity of 49.45% and a negative net margin of 69.30%. How do I buy shares of Provexis? Shares of PXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Provexis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Provexis investors own include Reckitt Benckiser Group (RB), Taylor Wimpey (TW), Bionano Genomics (BNGO), Bristol Myers Squibb (BMY), Bumble (BMBL), BEST (BEST) and Alibaba Group (BABA). Company Calendar Last Earnings12/31/2025Today5/19/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryTransportation Current SymbolLON:PXS CIKN/A Webwww.provexis.org Phone+44-1753-861777FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£619.15 thousand Net Margins-69.30% Pretax MarginN/A Return on Equity-49.45% Return on Assets-56.14% Debt Debt-to-Equity RatioN/A Current Ratio3.65 Quick Ratio6.21 Sales & Book Value Annual Sales£871.27 thousand Price / Sales27.65 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 0.01 per share Price / Book119.73Miscellaneous Outstanding Shares2,345,891,000Free FloatN/AMarket Cap£24.09 million OptionableNot Optionable Beta0.74 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (LON:PXS) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
